Proceedings of the International Association for Business and Society

Volume 30, 2019

Proceedings of the Thirtieth Annual Meeting

William P. Smith, Barrie E. Litzky
Pages 66-72

Crossing the Shareholder-First Border
The Case of Trek Therapeutics

This project investigates critical issues and events related to Trek Therapeutics experience as a public benefit corporation. We will present and discuss how Trek differentiates itself in an industry where the attention is on high prices supporting high investor returns. Trek’s benefit corporation status helped it garner favorable attention in some respects, but has also presented challenges, particularly when it comes to attracting new capital.